Save information for later
Sign Up

Learn About Hidradenitis Suppurativa

What is the definition of Hidradenitis Suppurativa?

Hidradenitis suppurativa, also known as acne inversa, is a chronic skin disease characterized by recurrent boil-like lumps (nodules) under the skin. The nodules become inflamed and painful. They tend to break open (rupture), causing abscesses that drain fluid and pus. As the abscesses heal, they produce significant scarring of the skin.

What are the causes of Hidradenitis Suppurativa?

In most cases, the cause of hidradenitis suppurativa is unknown. The condition probably results from a combination of genetic and environmental factors. Originally, researchers believed that the disorder was caused by the blockage (occlusion) of specialized sweat glands called apocrine glands. However, recent studies have shown that the condition actually begins with a blockage of hair follicles in areas of the body that also contain a high concentration of apocrine glands (such as the armpits and groin). The hair follicles have a buildup of a fibrous protein called keratin (hyperkeratosis). The blocked hair follicles trap bacteria, leading to inflammation and rupture. Researchers have several ideas about what initially causes the follicles to become blocked and why the nodules tend to recur, but the causes remain unclear.

How prevalent is Hidradenitis Suppurativa?

Hidradenitis suppurativa was once thought to be a rare condition because only the most severe cases were reported. However, recent studies have shown that the condition affects at least 1 in 100 people when milder cases are also considered. For reasons that are unclear, women are more commonly affected than men.

Is Hidradenitis Suppurativa an inherited disorder?

Hidradenitis suppurativa has been reported to run in families. Studies have found that 30 to 40 percent of affected individuals have at least one family member with the disorder. However, this finding may be an underestimate because affected individuals do not always tell their family members that they have the condition, and hidradenitis suppurativa is sometimes misdiagnosed as other skin disorders.

Who are the top Hidradenitis Suppurativa Local Doctors?
Afsaneh A. Alavi
Elite in Hidradenitis Suppurativa
Elite in Hidradenitis Suppurativa

Mayo Clinic

200 1st St Sw, 
Rochester, MN 
Languages Spoken:
English, Farsi
Accepting New Patients

Afsaneh Alavi is a Dermatologist in Rochester, Minnesota. Dr. Alavi is rated as an Elite provider by MediFind in the treatment of Hidradenitis Suppurativa. Her top areas of expertise are Hidradenitis Suppurativa, Pyoderma Gangrenosum, Livedo Reticularis, and Erythema Nodosum. Dr. Alavi is currently accepting new patients.

John W. Frew
Elite in Hidradenitis Suppurativa
Dermatology
Elite in Hidradenitis Suppurativa
Dermatology
1230 York Ave, 
New York, NY 
Languages Spoken:
English

John Frew is a Dermatologist in New York, New York. Dr. Frew is rated as an Elite provider by MediFind in the treatment of Hidradenitis Suppurativa. His top areas of expertise are Hidradenitis Suppurativa, Pyoderma Gangrenosum, Acne, Epidermolysis Bullosa, and Tissue Biopsy.

 
 
 
 
Learn about our expert tiers
Learn More
Tarannum Jaleel
Elite in Hidradenitis Suppurativa
Elite in Hidradenitis Suppurativa

Duke Dermatology Dawson Hall

77 Vilcom Center Dr, 
Chapel Hill, NC 
Languages Spoken:
English, Hindi, Spanish, Telugu
Accepting New Patients
Offers Telehealth

Tarannum Jaleel is a Dermatologist in Chapel Hill, North Carolina. Dr. Jaleel is rated as an Elite provider by MediFind in the treatment of Hidradenitis Suppurativa. Her top areas of expertise are Hidradenitis Suppurativa, Dissecting Cellulitis of the Scalp, Pyoderma Gangrenosum, and Vitiligo. Dr. Jaleel is currently accepting new patients.

What are the latest Hidradenitis Suppurativa Clinical Trials?
A Randomized, Double-blind, Placebo-controlled, Dose-ranging Phase 2 Study of Brivekimig Followed by a Maintenance Period in Participants With Moderate to Severe Hidradenitis Suppurativa

Summary: This is a Phase 2b, global, multicenter, sequential, randomized, double-blind, placebo-controlled, parallel group, dose-ranging study in participants with moderate to severe hidradenitis suppurativa. The purpose of this study is to assess the efficacy and safety of brivekimig in a dose-ranging study of participants with moderate to severe HS. Study details include: The study duration (per particip...

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Phase 2, Dose Ranging, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of BFB759 in Patients With Moderate to Severe Hidradenitis Suppurativa

Summary: This is a double-blind, placebo-controlled study where subjects are participating for approximately 36 to 40 weeks. The study compares how well BFB759 works and how safe it is compared with a placebo.

Who are the sources who wrote this article ?

Published Date: October 27, 2021
Published By: National Institutes of Health

What are the Latest Advances for Hidradenitis Suppurativa?